These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 31715010

  • 21. New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011).
    Tardy-Guidollet V, Menassa R, Costa JM, David M, Bouvattier-Morel C, Baumann C, Houang M, Lorenzini F, Philip N, Odent S, Guichet A, Morel Y.
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1180-8. PubMed ID: 24471566
    [Abstract] [Full Text] [Related]

  • 22. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
    Carlson AD, Obeid JS, Kanellopoulou N, Wilson RC, New MI.
    J Steroid Biochem Mol Biol; 1999 Apr; 69(1-6):19-29. PubMed ID: 10418977
    [Abstract] [Full Text] [Related]

  • 23. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
    David M, Forest MG.
    J Pediatr; 1984 Nov; 105(5):799-803. PubMed ID: 6334149
    [Abstract] [Full Text] [Related]

  • 24. Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Motaghedi R, Betensky BP, Slowinska B, Cerame B, Cabrer M, New MI, Wilson RC.
    J Pediatr Endocrinol Metab; 2005 Feb; 18(2):133-42. PubMed ID: 15751602
    [Abstract] [Full Text] [Related]

  • 25. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia.
    Lajic S, Wedell A, Bui TH, Ritzén EM, Holst M.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3872-80. PubMed ID: 9814461
    [Abstract] [Full Text] [Related]

  • 26. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):249-53. PubMed ID: 1619017
    [Abstract] [Full Text] [Related]

  • 27. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?
    Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Lajic S.
    Eur J Endocrinol; 2008 Sep; 159(3):309-16. PubMed ID: 18579553
    [Abstract] [Full Text] [Related]

  • 28. Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency.
    Lajic S, Nordenström A, Hirvikoski T.
    Endocr Dev; 2011 Sep; 20():96-105. PubMed ID: 21164263
    [Abstract] [Full Text] [Related]

  • 29. [Prenatal diagnosis and treatment of adrenogenital syndrome. Prevent virilization of female fetuses].
    Lajic S, Bui TH, Holst M, Ritzén M, Wedell A.
    Lakartidningen; 1997 Dec 10; 94(50):4781-6. PubMed ID: 9445959
    [Abstract] [Full Text] [Related]

  • 30. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.
    Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S.
    J Clin Endocrinol Metab; 2012 Jun 10; 97(6):1881-3. PubMed ID: 22466333
    [No Abstract] [Full Text] [Related]

  • 31. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
    Nimkarn S, New MI.
    Nat Clin Pract Endocrinol Metab; 2007 May 10; 3(5):405-13. PubMed ID: 17452967
    [Abstract] [Full Text] [Related]

  • 32. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Nimkarn S, New MI.
    Horm Res; 2007 May 10; 67(2):53-60. PubMed ID: 17047340
    [Abstract] [Full Text] [Related]

  • 33. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY, Pollack MS, Marshall RN, Immken L.
    N Engl J Med; 1990 Jan 11; 322(2):111-5. PubMed ID: 2403652
    [No Abstract] [Full Text] [Related]

  • 34. Prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    Levine LS, Pang S.
    J Pediatr Endocrinol; 1994 Jan 11; 7(3):193-200. PubMed ID: 7820212
    [Abstract] [Full Text] [Related]

  • 35. First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age.
    Van't Westeinde A, Karlsson L, Nordenström A, Padilla N, Lajic S.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):2575-86. PubMed ID: 32497228
    [Abstract] [Full Text] [Related]

  • 36. Hydrometrocolpos following prenatal dexamethasone treatment for congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Couper JJ, Hutson JM, Warne GL.
    Eur J Pediatr; 1993 Jan 01; 152(1):9-11. PubMed ID: 8444215
    [Abstract] [Full Text] [Related]

  • 37. Challenges in Prenatal Treatment with Dexamethasone.
    McCann-Crosby B, Placencia FX, Adeyemi-Fowode O, Dietrich J, Franciskovich R, Gunn S, Axelrad M, Tu D, Mann D, Karaviti L, Sutton VR.
    Pediatr Endocrinol Rev; 2018 Sep 01; 16(1):186-193. PubMed ID: 30371037
    [Abstract] [Full Text] [Related]

  • 38. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits.
    Miller WL, Witchel SF.
    Am J Obstet Gynecol; 2013 May 01; 208(5):354-9. PubMed ID: 23123167
    [Abstract] [Full Text] [Related]

  • 39. Acute encephalopathy with unilateral cortical-subcortical lesions in two unrelated kindreds treated with glucocorticoids prenatally for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: established facts and novel insight.
    Grunt S, Steinlin M, Weisstanner C, Schöning M, Mullis PE, Flück CE.
    Horm Res Paediatr; 2013 May 01; 80(1):57-63. PubMed ID: 23816834
    [Abstract] [Full Text] [Related]

  • 40. Successful prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Wudy SA, Homoki J, Teller WM.
    Eur J Pediatr; 1994 Aug 01; 153(8):556-9. PubMed ID: 7957400
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.